Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Smith & Nephew

Manufactures medical products and devices in the fields of Orthopaedic Reconstruction (joint replacement systems for ... read more Featured Products: More products

Download Mobile App




Smith & Nephew to Buy ArthroCare

By HospiMedica International staff writers
Posted on 11 Feb 2014
British medical technology company Smith & Nephew (London, United Kingdom) plans to buy medical device maker ArthroCare (Austin, TX, USA) to strengthen its sports medicine business.

The purchase price of approximately USD 1.7 billion, with an enterprise value of USD 1.5 billion, follows a strategic rationale of creating a comprehensive resection and repair portfolio with potential growth prospects. More...
The combination of ArthroCare’s radio frequency (RF) technology and Smith & Nephew’s strong mechanical blade portfolio will give customers a wider choice in resection technology. In joint repair, ArthroCare’s shoulder anchor innovation will complement Smith & Nephew’s strengths in knee repair.

The combined global footprint and channel presence will also add additional revenue opportunities from cross selling the combined portfolio and building upon shared capabilities in marketing and customer targeting. The adjacent Ear, Nose & Throat (ENT) business will also provide new growth opportunities. The acquisition will be subject to customary conditions, including a vote among ArthroCare shareholders and governmental clearances. ArthroCare will be integrated swiftly to minimize disruption to customers.

“ArthroCare and Smith & Nephew know each other well from our licensing and supply arrangements, and this is a natural transaction for both companies,” said David Fitzgerald, president and CEO of ArthroCare. “The Board believes that this transaction is in the best interest of our shareholders.”

“This is a compelling opportunity to add ArthroCare’s technology and highly complementary products to further strengthen our sports medicine business,” said Olivier Bohuon, CEO of Smith & Nephew. “Together, we will be able to generate significant additional revenue from the more comprehensive portfolio, combined sales force, and Smith & Nephew’s global footprint.”

Related Links:

Smith & Nephew 
ArthroCare



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.